Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Scale Our robust architectural and operational capacity allows us to support large-scale obesity and diabetes clinical trials across the globe, currently hosting over 600 active ePRO trials
doi:10.1038/s41467-025-60844-9
Hair loss was not prominently reported in phase 2 trial data, but trials are not always designed to capture delayed-onset effects such as telogen effluvium
Cost to patients : A flat $50 copay per 30-day supply, regardless of which Part D benefit phase you are in
US$ 26.81
US$ 21.38
US$ 26.61
